Guggenheim Capital’s Strata Critical Medical Inc SRTA Stock Holding History

Guggenheim Capital’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-63,798	Closed	-$174K	–	1594
2025 Q1	$174K	Sell	63,798 -12,012	-16%	-$43.1K	﹤0.01%	1551
2024 Q4	$322K	Sell	75,810 -13,282	-15%	-$50.6K	﹤0.01%	1423
2024 Q3	$262K	Sell	89,092 -3,503	-4%	-$11.2K	﹤0.01%	1666
2024 Q2	$322K	Sell	92,595 -3,066	-3%	-$10.2K	﹤0.01%	1627
2024 Q1	$273K	Sell	95,661 -3,630	-4%	-$11.2K	﹤0.01%	1687
2023 Q4	$350K	Sell	99,291 -547	-0.5%	-$1.57K	﹤0.01%	1604
2023 Q3	$259K	Buy	99,838 +58,301	+140%	+$205K	﹤0.01%	1676
2023 Q2	$164K	Buy	41,537 +29,046	+233%	+$92.2K	﹤0.01%	1798
2023 Q1	$42.2K	Buy	+12,491	New	+$50.9K	﹤0.01%	1900

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Guggenheim Capital's SRTA Position: Q2 2025 in Review

Guggenheim Capital sold out of Strata Critical Medical Inc (SRTA) in Q2 2025, closing a stake of 63,798 shares — an estimated $174K sold.

Guggenheim Capital first reported a position in SRTA in Q1 2023 and held it in 9 quarters. The position peaked at $350K in Q4 2023. 126 funds tracked by Wall St. Rank hold SRTA as of Q2 2025.

Guggenheim Capital reported no remaining Strata Critical Medical Inc position as of Q2 2025 after selling out during the quarter.
Guggenheim Capital sold 63,798 Strata Critical Medical Inc shares in Q2 2025, an estimated $174K.
Guggenheim Capital first reported a position in Strata Critical Medical Inc in Q1 2023 and held it in 9 quarters.
Guggenheim Capital's Strata Critical Medical Inc position peaked at $350K in Q4 2023.
126 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2025.

Based on Guggenheim Capital's 13F filing for Q2 2025, filed 13 Aug 2025.